Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase EARLY_PHASE1 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Gynecologic 2

Conditions

Obesity 2Endometrial Neoplasms 2Diabetes Mellitus 2Prostatic Neoplasms 1Overweight 1Insulin Resistance 1

Interventions

pembrolizumab 3Tirzepatide 2Paclitaxel 2Metformin 2Carboplatin 2tislelizumab 1olaparib 1niraparib 1montelukast 1Taxes 1Tablets 1Radiotherapy, Intensity-Modulated 1Progesterone 1Pafolacianine 1Morphine 1Laparotomy 1Hysterectomy 1Fluorescein 1Ezetimibe 1Dasatinib 1Biopsy 1Atorvastatin 1Anti-Inflammatory Agents, Non-Steroidal 1Anesthesia, Local 1Anesthesia, General 1Anesthesia, Conduction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Endometrial Neoplasms × Tirzepatide × Clear all
NCT07065552 2026-04-28

Tirzepatide in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
20 enrolled
GynecologicOther

Insulin Resistance, Obesity, Endometrial Neoplasms

NCT06751589 2026-04-13

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Recruiting
36 enrolled
GynecologicOther

Diabetes Mellitus, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡